Skip Navigation

Laboratory of Parasitic Diseases

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Alan Sher, Ph.D.

Photo of Alan Sher, Ph.D.

Chief, Laboratory of Parasitic Diseases
Chief, Immunobiology Section, LPD

Major Areas of Research

  • Mechanisms of host resistance and immune regulation in parasitic and mycobacterial infection
  • Role of innate pathogen recognition in the initiation of adaptive immunity and in CD4+ T-cell subset effector choice
  • Regulatory pathways limiting pathogen-induced Th1 immunopathology
  • Immunotherapeutic approaches to the treatment of infectious disease
 

Program Description

X ray from a pulmonary TB patient
X ray from a pulmonary TB patient presenting with paradoxical immune reconstitution inflammatory syndrome two weeks after initiation of anti-retroviral therapy. Credit: NIAID

The Immunobiology Section studies host resistance and immune regulation in parasitic and other infections of global importance. The ultimate goal of this work is immunologic disease intervention in the form of vaccination or immunotherapy. At the same time, our research on the host response to infection has provided insights into the effector functions and regulatory mechanisms used by the vertebrate immune system and in the role of innate pathogen recognition in these processes. Much of the work of the section is focused on the immunologic analysis in murine models of diseases induced by parasitic and bacterial agents (e.g., Toxoplasma gondii, Mycobacterium spp.), although the group is also engaged in several major clinical collaborations. The lab also has a major interest in the regulation of Th1-dependent immunopathology in T. gondii and mycobacterial infections as well as tuberculosis-HIV co-infection.

Biography

Dr. Sher received his Ph.D. from the University of California, San Diego, and did his postdoctoral training in the Division of Parasitology at the National Institute for Medical Research in Mill Hill, London. In 1980, after several years as a research associate and then assistant professor in the department of pathology at Harvard Medical School, he joined NIAID as a section chief in the Laboratory of Parasitic Diseases. Sher became chief of LPD in 2003 and was promoted to NIH Distinguished Investigator in 2011.

Awards

  • Bonazinga Award (Society for Leuckocyte Biology)
  • Bailey K. Ashford Medal (The American Society of Tropical Medicine and Hygiene)
  • U.S. PHS Superior Service Award
  • NIH Director’s Mentoring Award

Memberships

  • Fellow, American Academy of Microbiology
  • Fellow, American Association for the Advancement of Science
  • Brazilian Academy of Sciences

Editorial Boards

  • The Journal of Experimental Medicine (Senior Editor)
  • Faculty of 1000 (Section Head, Immunity to Infections)
  • Nature Reviews in Immunology

back to top


Research Group

Photo of Immunobiology Research Group Members
Dragana Jankovic, associate scientist; Katrin Mayer-Barber, fellow; Kevin Tosh, Ph. D. student; Nicoals Riteau, fellow; Chiaki Iwamura, fellow; Bruno Andrade, fellow; Diego Costa, fellow; Dave Kugler, Ph.D. student, Johns Hopkins GPP Gail Taylor, lab operations coordinator; Sandy Oland, animal procedure specialist; Sara Hieny, research technician

Selected Publications

Mayer-Barber KD, Andrade BB; Oland SD, Amaral EP, Barber DL, Gonzales J, Derrick S, Ruiru S, Nathella Pavan K, Wang W, Xing Y, Guolong Z, Ying C, Subash B, Marta C, Andres SM, Via LE, Barry III CE, Sher A. Host-directed therapy of tuberculosis based on interleukin-1-type I interferon crosstalk. Nature. 2014. In press.

Kugler DG, Mittelstadt PR, Ashwell JD, Sher A, Jankovic D. CD4+ T cells are trigger and target of the glucocorticoid response that prevents lethal immunopathology in toxoplasma infection. J Exp Med. 2013 Sep 23;210(10):1919-27.

Goldszmid RS, Caspar P, Rivollier A, White S, Dzutsev A, Hieny S, Kelsall B, Trinchieri G, Sher A. NK cell-derived interferon-γ orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection. J Immunol. 2012 Aug 1;189(3):1104-11.

Mayer-Barber KD, Andrade BB, Barber DL, Hieny S, Feng CG, Caspar P, Oland S, Gordon S, Sher A. Innate and adaptive interferons suppress IL-1α and IL-1β production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. Immunity. 2011 Dec 23;35(6):1023-34.

Mayer-Barber KD, Barber DL, Shenderov K, White SD, Wilson MS, Cheever A, Kugler D, Hieny S, Caspar P, Nunez G, Schlueter D, Flavell RA, Sutterwala FS, Sher A. Caspase-1 independent IL-1β production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo. J Immunol. 2010 Apr 1;184(7):3326-30.

Goldszmid RS, Coppens I, Lev A, Caspar P, Mellman I, Sher A. Host ER-parasitophorous vacuole interaction provides a route of entry for antigen cross-presentation in Toxoplasma gondii-infected dendritic cells. J Exp Med. 2009 Feb 16;206(2):399-410.

Visit PubMed for a complete publication list.

back to top

Recent Accomplishments

  • Demonstration of the role of TLR 11-recognition of parasite profilin in the induction of IL-12 during T. gondii infection
  • Identification of the T2 ribonuclease Omega-1 as the schistosome egg component responsible for conditioning dendritic cells (DC) to trigger Th2 responses
  • Elucidation of endoplasmic reticulum fusion with parasitophorous vacuoles as a mechanism of cross-presentation in T. gondii-infected DC
  • Studies identifying the respective role of toll-like receptors (TLR), IL-1R signaling, and the inflammasome in host resistance to M. tuberculosis and in the adjuvant activity of the mycobacterial component in Complete Freunds Adjuvant
  • Identification of IL-10-producing Th1 cells as major regulators of immunopathology in T. gondii infection
  • Discovery of major roles for the GTPase Irgm1(LRG47) in the regulation of hematopoietic stem development and in interferon (IFN)-dependent autophagic cell death in T lymphocytes
  • First description of in situ cellular dynamics with mycobacterial granulomas in a mammalian host
  • Discovery of role of lipoxins in suppressing cellular response to M. tuberculosis, thereby promoting infection
  • Elucidation of opposing roles of IL-1 and interferons in host resistance to M. tuberculosis and the development of an experimental host therapy for TB based on the manipulation of these cytokines with eicosanoids
  • Development of a murine model for studying the pathogenesis of immune reconstitution inflammatory syndrome (IRIS)
  • Discovery of a role of glucocorticoids in the self-regulation of effector CD4+ T-cell function in toxoplasma infection
  • Use of hemoxygenase-1 as a clinical biomarker for active TB and other lung diseases
 

Last Updated February 11, 2013